| Early alteration of epigenetic-related transcription in Huntington’s disease mouse models I Hervás-Corpión, D Guiretti, M Alcaraz-Iborra, R Olivares, ... Scientific reports 8 (1), 9925, 2018 | 46 | 2018 |
| Transcriptional correlates of the pathological phenotype in a Huntington’s disease mouse model A Gallardo-Orihuela, I Hervás-Corpión, C Hierro-Bujalance, ... Scientific Reports 9 (1), 18696, 2019 | 18 | 2019 |
| The epigenetics of glioma stem cells: a brief overview LM Valor, I Hervás-Corpión Frontiers in Oncology 10, 602378, 2020 | 16 | 2020 |
| Targeting protein kinase C in glioblastoma treatment N Geribaldi-Doldán, I Hervás-Corpión, R Gómez-Oliva, ... Biomedicines 9 (4), 381, 2021 | 15 | 2021 |
| TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory I Ausejo-Mauleon, S Labiano, D de la Nava, V Laspidea, M Zalacain, ... Cancer cell 41 (11), 1911-1926. e8, 2023 | 12 | 2023 |
| Molecular pathogenesis and peripheral monitoring of adult fragile X-associated syndromes LM Valor, JC Morales, I Hervás-Corpión, R Marín International Journal of Molecular Sciences 22 (16), 8368, 2021 | 7 | 2021 |
| Potential diagnostic value of the differential expression of histone H3 variants between low-and high-grade gliomas I Hervás-Corpión, A Gallardo-Orihuela, I Catalina-Fernández, ... Cancers 13 (21), 5261, 2021 | 5 | 2021 |
| Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas I Hervás-Corpión, J Navarro-Calvo, P Martín-Climent, M Iriarte-Gahete, ... Cells 12 (3), 374, 2023 | 2 | 2023 |
| Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation F Cano-Cano, F Martín-Loro, A Gallardo-Orihuela, ... Scientific Reports 14 (1), 4176, 2024 | 1 | 2024 |
| Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success I Hervás-Corpión, MM Alonso International Review of Cell and Molecular Biology 379, 169-188, 2023 | 1 | 2023 |
| The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models D de la Nava, I Ausejo-Mauleon, V Laspidea, M Gonzalez-Huarriz, ... Neuro-oncology, noae066, 2024 | | 2024 |
| THE NEUROINFLAMMATORY COMPONENT OF HUNTINGTON'S DISEASE IS PRESENT IN THE RETINA OF MOUSE MODELS L Valor, A Arroba, F Cano-Cano, F Martín-Loro, ... IBRO Neuroscience Reports 15, S510, 2023 | | 2023 |
| Retinal affectation in Huntington’s disease mouse models concurs with a local innate immune response AI Arroba, A Gallardo-Orihuela, F Cano-Cano, F Martín-Loro, ... bioRxiv, 2023.01. 17.523578, 2023 | | 2023 |
| B02 Is mouse retinal affectation by HTT cag expansion suitable for modelling the neuroinflammatory component of Huntington’s disease? LM Valor, F Cano-Cano, A Gallardo-Orihuela, F Martín-Loro, ... Journal of Neurology, Neurosurgery and Psychiatry 93 (Suppl 1), A15-A15, 2022 | | 2022 |
| A14 Retinal and striatal profiling of the r6/1 mouse model of huntington’s disease LM Valor, A Gallardo-Orihuela, F Cano-Cano, L Gómez-Jaramillo, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (Suppl 1), A6-A6, 2021 | | 2021 |
